| Product NDC: | 51079-139 |
| Proprietary Name: | donepezil hydrochloride |
| Non Proprietary Name: | DONEPEZIL HYDROCHLORIDE |
| Active Ingredient(s): | 10 mg/1 & nbsp; DONEPEZIL HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51079-139 |
| Labeler Name: | UDL Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021720 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110112 |
| Package NDC: | 51079-139-56 |
| Package Description: | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-139-56) > 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (51079-139-30) |
| NDC Code | 51079-139-56 |
| Proprietary Name | donepezil hydrochloride |
| Package Description | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-139-56) > 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (51079-139-30) |
| Product NDC | 51079-139 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DONEPEZIL HYDROCHLORIDE |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20110112 |
| Marketing Category Name | NDA |
| Labeler Name | UDL Laboratories, Inc. |
| Substance Name | DONEPEZIL HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |